Dashboard
Manage Tickers

EYEN

Nasdaq eyenovia.com


()    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ 0.5649
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-14-2024 06-30-2024 10-Q
2 05-15-2024 03-31-2024 10-Q
3 03-18-2024 12-31-2023 10-K
4 11-13-2023 09-30-2023 10-Q
5 08-11-2023 06-30-2023 10-Q
6 05-12-2023 03-31-2023 10-Q
7 03-31-2023 12-31-2022 10-K
8 11-14-2022 09-30-2022 10-Q
9 08-11-2022 06-30-2022 10-Q
10 05-13-2022 03-31-2022 10-Q
11 03-30-2022 12-31-2021 10-K
12 11-12-2021 09-30-2021 10-Q
13 08-12-2021 06-30-2021 10-Q
14 05-14-2021 03-31-2021 10-Q
15 03-30-2021 12-31-2020 10-K
16 11-12-2020 09-30-2020 10-Q
17 08-14-2020 06-30-2020 10-Q
18 05-14-2020 03-31-2020 10-Q
19 03-30-2020 12-31-2019 10-K
20 11-13-2019 09-30-2019 10-Q
21 08-13-2019 06-30-2019 10-Q
22 05-14-2019 03-31-2019 10-Q
23 03-27-2019 12-31-2018 10-K
24 11-13-2018 09-30-2018 10-Q
25 08-14-2018 06-30-2018 10-Q
26 05-09-2018 03-31-2018 10-Q
27 04-02-2018 12-31-2017 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

eyen-shares-are-trading-higher-today-what-you-need-to-know
EYEN Shares Are Trading Higher Today: What...
09/09/2024 20:11:50

Eyenovia shares are surging Monday in response to the company's announcement of the launch of a new FDA-approved ophthalmic...

formosa-pharma-and-eyenovia-set-to-launch-new-fda-approved-ophthalmic-drug-in-us
Formosa Pharma and Eyenovia Set to Launch ...
09/09/2024 07:02:52

Formosa Pharmaceuticals, Inc. (hereinafter referred to as "Formosa Pharma," 6838.TW) announced the successful first shi...

eyenovias-taiwan-based-partner-formosa-pharmaceutical-was-granted-a-taiwan-export-license-for-clobetasol-propionate-ophthalmic-suspension-005-to-allow-for-shipment-of-commercial-product-to-the-us
Eyenovia's Taiwan-Based Partner Formosa Ph...
09/05/2024 11:07:23

eyenovia-appoints-andrew-jones-as-cfo-current-cfo-john-gandolfo-is-retiring-and-will-remain-with-company-through-november
Eyenovia Appoints Andrew Jones As CFO; Cur...
09/03/2024 11:05:46

eyenovia-ceo-michael-m-rowe-buys-50000-shares-at-an-average-price-of-057
Eyenovia CEO Michael M. Rowe Buys 50,000 S...
08/27/2024 17:10:23

- Form 4

why-is-eye-disease-focused-eyenovia-stock-trading-higher-on-thursday
Why Is Eye Disease Focused Eyenovia Stock ...
08/22/2024 18:20:49

Eyenovia (stock surges with high trading volume after announcing a $5.14 million offering to fund commercialization of Mydcombi...

nasdaq-gains-05-tjx-earnings-top-estimates
Nasdaq Gains 0.5%; TJX Earnings Top Estimates
08/21/2024 18:43:06

crude-oil-down-1-bigbearai-shares-spike-higher
Crude Oil Down 1%; BigBear.ai Shares Spike...
08/21/2024 16:15:00

why-eyenovia-eyen-stock-is-getting-hammered-today
Why Eyenovia (EYEN) Stock Is Getting Hamme...
08/21/2024 14:36:12

Eyenovia shares are trading lower by 35% Wednesday morning. The company announced plans to sell shares or pre-funded warrants i...

us-stocks-higher-target-posts-upbeat-earnings
US Stocks Higher; Target Posts Upbeat Earn...
08/21/2024 14:29:19

eyenovia-agrees-to-sell-1285m-shares-at-040-each-expected-to-raise-514m-in-gross-proceeds-for-funding-commercialization-and-pediatric-myopia-study
Eyenovia Agrees To Sell 12.85M Shares At $...
08/21/2024 13:30:10

why-keysight-technologies-shares-are-trading-higher-by-around-11-here-are-20-stocks-moving-premarket
Why Keysight Technologies Shares Are Tradi...
08/21/2024 09:47:26

eyenovia-plans-to-offer-sell-shares-of-its-common-stock-or-pre-funded-warrants-in-lieu-thereof-via-offering-no-terms-disclosed
Eyenovia Plans To Offer, Sell Shares Of It...
08/20/2024 21:12:23

The Company intends to use the net proceeds from this Offering to fund commercialization activities for Mydcombi and clobetasol...

hc-wainwright--co-reiterates-buy-on-eyenovia-maintains-12-price-target
HC Wainwright & Co. Reiterates Buy on Eyen...
08/13/2024 18:18:51

HC Wainwright & Co. analyst Matthew Caufield reiterates Eyenovia (NASDAQ:EYEN) with a Buy and maintains $12 price target.

eyenovia-q2-2024-adj-eps-016-misses-015-estimate-sales-22625k-miss-915667k-estimate
Eyenovia Q2 2024 Adj. EPS $(0.16) Misses $...
08/12/2024 20:12:29

Eyenovia (NASDAQ:EYEN) reported quarterly losses of $(0.16) per share which missed the analyst consensus estimate of $(0.15) by...

formosa-pharmaceuticals-signs-non-binding-terms-agreement-with-eyenovia-to-co-develop-clobetasol-propionate-ophthalmic-suspension-for-dry-eye-disease-relief
Formosa Pharmaceuticals Signs Non-Binding ...
08/07/2024 12:01:54

eyenovia--sgn-nanopharma-collaborate-to-work-to-develop-sgns-micellar-nanoparticle-platform-platform-based-cyclosporine-formulation-for-use-with-eyenovias-optejet-dispenser
Eyenovia & SGN Nanopharma Collaborate To W...
07/30/2024 12:04:50

Eyenovia, Inc. (NASDAQ:EYEN), a commercial-stage ophthalmic company with two FDA-approved products and a late-stage asset in pe...

hc-wainwright--co-reiterates-buy-on-eyenovia-maintains-12-price-target
HC Wainwright & Co. Reiterates Buy on Eyen...
07/24/2024 10:18:15

HC Wainwright & Co. analyst Matthew Caufield reiterates Eyenovia (NASDAQ:EYEN) with a Buy and maintains $12 price target.

eyenovia-inks-collaboration-agreement-with-senju-pharmaceutical-for-potential-new-treatment-for-chronic-dry-eye-disease
Eyenovia Inks Collaboration Agreement With...
07/23/2024 11:02:59

Core News & Articles
NovaBay and Eyenovia Begin Co-Promotion of...
07/01/2024 10:54:58

NovaBay® Pharmaceuticals, Inc. (NYSE:NBY), a company developing and commercializing high-quality eyecare products, and Eyenovia...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION